Inova Digital

The Washington Post reports that Texas has set aside $50 million for ibogaine clinical trials; a quiet but meaningful step forward for psychedelic-assisted care. In our latest blog we exploring how this funding could shift standards, open new funding channels, and broaden access for veterans. Take a look tomorrow and let us know what changes you’re anticipating. 👇

Mushrooms to the rescue! 🍄✨
One psilocybin dose reduced alcohol use by 37% in a new study. Could psychedelics be the ultimate game changer for addiction?

Home Research Square is a preprint platform that makes research communication faster, fairer, and more useful.

Website launch days always have us like 😬😬😬 > 😭😭😭 > 😍😍😍

The FDA plans to microdose our comments about PTSD treatment 👀🔎

On September 6th, the FDA is hosting a big conversation about PTSD treatments, and yes, psychedelics are on the table.

This is your moment to chime in and help steer the future of mental health treatment.

Submit your comments by September 20th, or just register to sit in on the action (virtually, of course).

Your input could make M**A therapy as normal as therapy dogs. 🐶💊 (and registration is free.)

Advancing Treatments for Post-Traumatic Stress Disorder | Reagan-Udall Foundation The Reagan-Udall Foundation for the FDA, in support of FDA’s ongoing focus on PTSD, will convene “Advancing Treatments for Post-Traumatic Stress Disorder,” a public meeting with stakeholder comment.

We are grateful to be the ones elevating your impact in the dawn of the psychedelic renaissance.

Drive the right traffic, to the right sites, with the right software, call at the right times, and grow in the right direction. Elevate the impact of your psychedelic therapy clinic.